Innovation In Phase 1 Clinical Development

Practical approaches to preclinical and phase I development and data analysis in order to minimise risk, improve predicted clinical outcomes and enable faster go / no-go decisions

17 19 September 2012

5 speakers

  • Miro Venturi Ph.D, Site Head - Oncology Biomarkers Pharma Research & Early Development, Roche
  • Annarita Meneguz, Director of the National Commission for the Preclinical Assessment and Evaluation of Admissibility to Phase I, Italian Heath Ministry
  • Chiara Falciani, CEO, Setlance
  • JW McBlane, Pharmaceutical Assessor, MHRA
  • Paolo Bettica, Director Clinical Development Operations, Italfarmaco Spa

1 person tracking this event

  • Veronica Araujo

Tell your friends!

Share this event with your friends on Twitter

Share

See something wrong?

Report an issue with this event